Nobivac Pi, Lyophilisate and Solvent for Suspension for Injection for Dogs
Nobivac Pi, Lyophilisate and Solvent for Suspension for Injection for Dogs
Authorised
- Canine parainfluenza virus, strain Cornell, Live
Product identification
Medicine name:
Nobivac Pi, Lyophilisate and Solvent for Suspension for Injection for Dogs
Nobivac PI Lyofilisaat en oplosmiddel voor suspensie voor injectie
Nobivac PI Lyophilisat et solvant pour suspension injectable
Nobivac PI Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
- Canine parainfluenza virus, strain Cornell, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parainfluenza virus, strain Cornell, Live5.50log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD08
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID4): 1 Box with 50 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (50 Dose, 50 millilitre(s))
- (ID3): 1 Box with 25 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (25 Dose, 25 millilitre(s))
- (ID2): 1 Box with 10 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (10 Dose, 10 millilitre(s))
- (ID1): 1 Box with 5 Box with (1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)) (5 Dose, 5 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V259016
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0286/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Slovenia
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: